Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Simonton

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Open Heart|July 5, 2017
Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humansBoris Vesga, Hector Hernandez, Sergio Higuera, et al.
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2016
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trialYoshinobu Onuma, Yohei Sotomi, Hiroki Shiomi, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
JACC. Cardiovascular Interventions|January 11, 2020
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 YearsYoshinobu Onuma, Yasuhiro Honda, Taku Asano, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Open Heart|July 5, 2017
Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humansBoris Vesga, Hector Hernandez, Sergio Higuera, et al.
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2016
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trialYoshinobu Onuma, Yohei Sotomi, Hiroki Shiomi, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
JACC. Cardiovascular Interventions|January 11, 2020
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 YearsYoshinobu Onuma, Yasuhiro Honda, Taku Asano, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Pageof 2